RONEN JUSTIN HAREL DO NPI 1750671228

NPI Details

Ronen Justin Harel, DO is a hematology and oncology internal medicine in Middletown, NY with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Ronen Justin Harel, DO NPI is 1750671228. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:2011

The provider's business location address is:

185 RYKOWSKI LN
MIDDLETOWN, NY
ZIP 10941-055
Phone: (845) 703-6999
Fax: (845) 703-6297

The NPI 1750671228 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Liver enzyme (sgot), level (HCPCS:84450)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Bilirubin level, total (HCPCS:82247)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Albumin (protein) level (HCPCS:82040)
• Total protein level, blood (HCPCS:84155)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ferritin (blood protein) level (HCPCS:82728)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Red blood count, automated test (HCPCS:85045)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Blood test, clotting time (HCPCS:85610)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Unclassified drugs (HCPCS:J3490)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Calcium level, total (HCPCS:82310)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection of drug or substance into vein (HCPCS:96374)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Folic acid level, serum (HCPCS:82746)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 4/18/2011 and was last updated on 3/4/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.